Myths vs facts: IgE and menopause

The question of myths vs. facts regarding IgE and menopause requires careful distinction. IgE (immunoglobulin E) is primarily involved in immediate allergic reactions (type I hypersensitivity). There is no strong evidence that IgE levels are directly altered by menopause or that IgE testing is useful for diagnosing or managing menopausal symptoms. A common myth is that elevated IgE is a hallmark of menopause – in reality, IgE increases are driven by allergies, parasitic infections, or rare immune disorders, not by hormonal changes alone. Fact: Menopause does influence immune function (e.g., via estrogen decline), but IgE is not a validated biomarker for this transition. Studies show inconsistent associations between IgE and hormonal status, with small effect sizes. Consumers should be wary of DTC IgG food sensitivity tests (often misleadingly marketed as 'intolerance' tests); IgE tests are only indicated for suspected allergies. For menopause-related concerns, evidence-based options (hormone therapy, lifestyle modifications) are recommended. The provided context lacks direct studies on IgE and menopause, so this answer draws on general immunology and allergology principles.